Back to search

France· FR:61653489

DUTASTERIDE ARROW LAB 0,5 mg, capsule molle

A dutasteride product containing dutastéride, registered in France by ARROW GENERIQUES, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC G04CB02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedDUTASTERIDE ARROW LAB 0,5 mg, capsule…ATCG04CB02REGISTER NO.FR:61653489PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Dutasteride is registered in 18 of 19 countries.

Countries holding a registration under ATC G04CB02 (dutasteride), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose

Dutasteride · ATC G04CB02

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dutasteride costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), the median price runs from $0.27 in France to $0.80 in Switzerland — a ×2.9 gap.

  • France: $0.27 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Dutasteride · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.80
  • ES Spain$0.76
  • IT Italy$0.32
  • FR France$0.27
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
DUTASTÉRIDE
Manufacturer
ARROW GENERIQUES
Country
France (FR)
ATC code
G04CB02
ATC class
Dutasteride
Defined daily dose
0.5 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930098660
    plaquette(s) PVC PVDC aluminium de 30 capsule(s)
    EUR 7.23

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

178 interactions on record for dutasteride.

Graded by severity as the source publishes them — 66 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dutasteride · interactions on record

178 records

  • 66 moderate
  • 112 info

Most severe, free to view

  • ClotrimazoleA01AB18moderate
  • CimetidineA02BA01moderate
  • AprepitantA04AD12moderate
  • MiconazoleA07AC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dutasteride in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dutasteride products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Avodart, Dutaglandin
  • Belgium · Avodart, Dutasteride Ab
  • Bulgaria · Дутастерид Акорд, Дутрис
  • Cyprus · Avodart, Rafuster
  • Czechia · Adadut, Avodart
  • Germany · Avodart, Dutascar
  • Denmark · Deridust, Dutasterid "alkaloid"
  • Estonia · Avodart, Dutasteride Elvim
  • Spain · Avidart, Dutacap
  • Finland · Avodart, Dutasteride Krka
  • United Kingdom (Northern Ireland) · Avodart, Dutasteride
  • Greece · Avodart, Dastidem
  • Croatia · Avodart, Dupro
  • Hungary · Avodart
  • Ireland · Avodart, Dutasteride Krka
  • Iceland · Dutasteride Alvogen, Dutasteride Medical Valley
  • Italy · Avodart, Decuster
  • Lithuania · Dortilla, Dutasteride Elvim
  • Luxembourg · Avodart
  • Latvia · Avodart, Dutasteride Elvim
  • Malta · Avodart, Dutalan
  • Netherlands · Avodart, Dutasteride Aurobindo
  • Norway · Dutasteride Medical Valley
  • Poland · Adadut, Avodart
  • Portugal · Aripsa, Avodart
  • Romania · Asium, Avodart
  • Sweden · Avodart, Duagen
  • Slovenia · Amdut, Avodart
  • Slovakia · Adadut, Dutalan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9c5e6d0-997b-420a-bb00-7c7feb71817c
GET /v1/drugs/d9c5e6d0-997b-420a-bb00-7c7feb71817c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61653489",
  "date_amm": "2017-06-19",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "DUTASTÉRIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "capsule molle",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about dutasteride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.